TABLE 1.
Pathologies affecting cardiac sensory neurons | Disease | Clinical cardiac symptoms | References | Available animal models of the disease | References | |
---|---|---|---|---|---|---|
Primary neuropathies | Inherited | Charcot–Marie–Tooth disease | Noncompaction cardiomyopathy, increased incidence of arrhythmias, and embolic complications | Eltawansy et al., 2015 | CMT1: PMP22 overexpressed transgenic rodents |
Huxley et al. 1998 Sereda et al. 1996 |
Familial dysautonomy (HSAN Type III) | Cardiovascular instability, postural hypotension, episodic hypertension, QT variability, and ECG abnormalities |
Goldstein et al., 2008 Solaimanzadeh et al. 2008 |
Ikbkap conditional‐knockout mouse lines, Ikbkap flox/flox and ikbkap δ20/flox |
Dietrich et al., 2012 Ohlen et al., 2017 |
||
Hereditary transthyretin‐mediated amyloidosis | Refractory cardiomyopathy, orthostatic hypotension, and arrhythmias |
Adams et al., 2019 Lai et al., 2019 |
Mouse expressing human transthyretin V30M in a heat shock transcription factor 1 null background | Santos et al., 2010 | ||
Friedreich's ataxia | Hypertrophic cardiomyopathy, atrial fibrillation, and ventricular tachycardia | Peverill et al., 2018 | Conditional frataxin knockout mouse | Puccio et al., 2001 | ||
Secondary neuropathies | Metabolic | Diabetes mellitus (Type 1) | Diastolic cardiomyopathy and heart failure with reduced ejection fraction | Voulgari et al., 2010 | Single high dose of STZ or multiple moderate dose of STZ |
Bakovic et al., 2018 Kellogg, Converso, Wiggin, Stevens, and Pop‐Busui, 2009 Grise et al. 2016 Xuan et al., 2015 |
Diabetes mellitus (Type 2) | Increased heart rate | Aune et al., 2017 | High‐fat diet for 14 weeks and single dose of STZ (30 mg·kg−1) | Li et al., 2017 | ||
Pre‐diabetes | N/A | N/A | Single low‐dose of STZ (20 mg·kg−1) and high fat diet | Koncsos et al., 2016 | ||
Alcoholism | No characteristic cardiovascular involvement | Koike et al., 2003 | Mouse model of chronic plus binge alcohol feeding‐induced ethanol intoxication | Matyas et al., 2016 | ||
Autoimmune | Systemic lupus erythematosus | Left ventricular systolic and diastolic dysfunction | Chen et al., 2016 | N/A | N/A | |
Rheumatoid arthritis | Conduction disturbances and arrhythmias |
Buleu et al., 2019 Seferovic et al., 2006 |
TNF‐α‐transgenic mouse, K/bxn mouse, Collagen‐induced arthritis/Collagen‐antibody‐induced arthritis in rats and mice, Zymosan‐induced arthritis in rat, and methylated BSA mouse model |
Asquith, Miller, McInnes, and Liew, 2009 Choudhary et al., 2018 |
||
Sjögren's syndrome | Lower heart rate and BP variability | Kovacs et al., 2004 | Autoimmune regulator gene deficient (Aire−/−) mice | Chen et al., 2017 | ||
Toxic | Paclitaxel, Vincristine, and Adriamycin | Degenerative morphological alterations in cutaneous C‐fibre | Boyette‐Davis, Xin, Zhang, and Dougherty, 2011; Dux et al., 1999; Siau et al., 2006 | N/A | N/A | |
Statins | N/A | N/A | N/A | N/A | ||
Antibiotics/antiviral agents | N/A | N/A | N/A | N/A | ||
Industrial/agricultural toxins | N/A | N/A | N/A | N/A | ||
Other | Vitamin deficiency | Atrial fibrillation and sinus tachycardia | Puntambekar et al., 2009 | N/A | N/A | |
Hypothyroidism | N/A | N/A | N/A | N/A | ||
Viral infections (HIV, Zika, and hepatitis C) | N/A | N/A | N/A | N/A | ||
Guillain–Barré sy. | Arrhythmias | Vucic, Kiernan, and Cornblath, 2009 | N/A | N/A |
Note. N/A indicates no available data in the literature.